Literature DB >> 19573091

The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients.

H Töz1, D Nart, I Turan, G Ersöz, M Seziş, G Aşçi, M Ozkahya, A Zeytinoğlu, S Erensoy, E Ok.   

Abstract

BACKGROUND: The aim of this study was to compare the clinical and histopathological course of HCV infection acquired before and during or after renal transplantation.
METHODS: According to HCV status, 197 RT patients were divided into three groups. At the time of RT, anti-HCV antibody was positive in 47 patients (pre-RT HCV group). In 27 patients, in whom anti-HCV negative at the time of RT, anti-HCV and/or HCV RNA was found to be positive following an ALT elevation episode after RT (post-RT HCV group). Both anti-HCV and HCV RNA were negative at all times in remaining 123 patients (control group).
RESULTS: Liver biopsy was performed in 31 of 47 patients in pre-RT and 24 of 27 in post-RT HCV group after RT. Duration of follow-up was similar in all groups with a mean of 7.1 +/- 4.0 yr. Ascites and encephalopathy were seen in only post-RT HCV group (22%). Histological grade (6.5 +/- 2.7 vs. 4.1 +/- 1.4) and stage (2.0 +/- 1.5 vs. 0.8 +/- 0.8) was significantly severe in post-RT HCV group (p < 0.01). Three patients died due to liver failure in post-RT HCV group.
CONCLUSIONS: HCV infection acquired during or after RT shows a severe and rapidly progressive clinicopathological course, which is significantly different from pre-transplant anti-HCV positive patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573091     DOI: 10.1111/j.1399-0012.2009.01017.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

Review 1.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

2.  Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection.

Authors:  Nilay Danış; Hüseyin Toz; Nalan Ünal; Mümtaz Yılmaz; İlker Turan; Fulya Günşar; Zeki Karasu; Galip Ersöz; Mehmet Özkahya; Ulus Salih Akarca
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

Review 3.  Hepatitis C and its impact on renal transplantation.

Authors:  Jose M Morales; Fabrizio Fabrizi
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

4.  The impact of Hepatitis C virus infection on kidney transplantation outcomes: A systematic review of 18 observational studies: The impact of HCV on renal transplantation.

Authors:  Zohreh Rostami; Mohammad Hossien Nourbala; Seyed Moayed Alavian; Fatemeh Bieraghdar; Yunes Jahani; Behzad Einollahi
Journal:  Hepat Mon       Date:  2011-04       Impact factor: 0.660

5.  Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation: A Multicenter Cohort Study in Korea.

Authors:  Jeonghwan Lee; Jang-Hee Cho; Jong Soo Lee; Dong-Won Ahn; Chan-Duck Kim; Curie Ahn; In Mok Jung; Duck Jong Han; Chun Soo Lim; Yon Su Kim; Young Hoon Kim; Jung Pyo Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.